Patent Assignment
Reel/Frame 034638/0930
Change of Name
Recorded: 2014-12-15
Pages: 7
Assignor
PRECISION THERAPEUTICS, INC.
Executed: 2014-11-20
Assignee
HELOMICS CORPORATION
2516 JANE STREET, PITTSBURGH, PENNSYLVANIA, 15203
Covered Properties
(77)
Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics
PCT:
PCT/US2006/034469 ↗
Methods for Evaluating Angiogenic Potential in Culture
PCT:
PCT/US2008/058001 ↗
Methods for Selecting Active Agents for Cancer Treatment
PCT:
PCT/US2008/079964 ↗
Methods for Predicting a Patient's Response to Egfr Inhibitors
PCT:
PCT/US2009/043973 ↗
Methods of Simulating Chemotherapy for a Patient
PCT:
PCT/US2009/063060 ↗
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
PCT:
PCT/US2010/036854 ↗
Methods and Markers for Predicting Responses to Chemotherapy
PCT:
PCT/US2010/038641 ↗
Methods for Predicting a Cancer Patient's Response to Antifolate Therapy
PCT:
PCT/US2010/039456 ↗
Multi Drug Response Markers for Breast Cancer Cells
PCT:
PCT/US2010/058499 ↗
Biological Pathways Associated with Chemotherapy Treatment in Breast Cancer
PCT:
PCT/US2010/058512 ↗
Methods for Predicting a Cancer Patient's Response to Sunitinib
PCT:
PCT/US2011/025281 ↗
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
PCT:
PCT/US2011/062196 ↗
Method for Preparing Cell Cultures from Biocogial Specimens for Chemot Herapeutic and Other Assays
Patent:
5,728,541 →
Application:
08/679,056 →
Method for Culturing and Assaying Cells
Patent:
6,933,129 →
Application:
09/039,957 →
Precise Efficacy Assay Methods for Active Agents Including Chemotherapeutic Agents
Patent:
6,900,027 →
Application:
09/040,161 →
Staining Agents and Protocols for Characterizing Malignant Cells in Culture
Application:
09/095,993 →
Publication:
US 2002/0168679
Method for Using Multicellular Particulates to Analyze Malignant or Hyperproliferative Tissue
Method for the genetic analysis of proliferating cells
Application:
09/691,492 →
Method for Preparing Cell Cultures from Biological Specimens for Chemotherapeutic and Other Assays
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
Application:
10/208,480 →
Publication:
US 2004/0023375
Methods for assessing efficacy of chemotherapeutic agents
Application:
10/336,659 →
Publication:
US 2004/0072722
Method for tandem genomic/proteomic analysis of proliferating cells
Application:
10/399,563 →
Publication:
US 2004/0086888
Method of Preparing Cell Cultures from Biological Specimens for Assaying a Response to an Agent
Method for Selecting Therapeutic Agents for Cancer
Method for Preparing Cell Cultures from Biological Specimens for Assaying Secreted Factors
Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
Application:
11/514,172 →
Method for Preparing Cell Cultures from Biological Specimens for Chemotherapeutic and Other Assays
Methods for Assessing Efficacy of Chemotherapeutic Agents
Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics
Methods for Determining Efficacy of Chemotherapeutic Agents for a Patient Prior to Treatment
Method for Selecting Therapeutic Agents for Cancer Treatment
Methods for Determining Efficacy of Chemotherapeutic Agents
Methods for Selecting Active Agents for Cancer Treatment
Methods for Predicting a Patient's Response to Egfr Inhibitors
Application:
12/466,129 →
Publication:
US 2009/0286276
Methods for Assessing Efficacy of Chemotherapeutic Agents
Methods for Evaluating Angiogenic Potential in Culture
Application:
12/530,541 →
Publication:
US 2010/0216168
Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics
Assaying Cellular Markers for the Evaluation of Tumors
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
Application:
12/791,425 →
Publication:
US 2010/0331210
Methods for Predicting a Patient's Response to Egfr Inhibitors
Application:
12/795,286 →
Publication:
US 2010/0311084
Methods for Predicting a Cancer Patient's Response to Antifolate Chemotherapy
Application:
12/820,573 →
Publication:
US 2011/0014644
Methods for Determining Efficacy of Chemotherapeutic Agents
Calibration Device and Methods for Use with a Liquid Handler
Application:
12/878,239 →
Publication:
US 2012/0065912
Methods for Assessing Efficacy of Chemotherapeutic Agents
Multi Drug Response Markers for Breast Cancer Cells
Application:
12/957,604 →
Publication:
US 2011/0129822
Biological Pathways Associated with Chemotherapy Outcome for Breast Cancer
Application:
12/957,608 →
Publication:
US 2011/0130302
Methods for Predicting a Cancer Patient's Response to Sunitinib
Application:
13/029,895 →
Publication:
US 2011/0207119
Methods of Simulating Chemotherapy for a Patient
Application:
13/127,337 →
Publication:
US 2011/0238322
Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy
Application:
13/164,552 →
Publication:
US 2012/0077687
Methods for Determining Efficacy of Chemotherapeutic Agents
Application:
13/267,581 →
Publication:
US 2012/0088264
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
Application:
13/304,990 →
Publication:
US 2012/0214679
Methods and Markers for Predicting Responses to Chemotherapy
Application:
13/378,507 →
Methods for Selecting Active Agents for Cancer Treatment
Application:
13/461,079 →
Publication:
US 2012/0219982
Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy
Application:
13/471,915 →
Publication:
US 2012/0323594
Chemo-Sensitivity Assays Using Tumor Cells Exhibiting Persistent Phenotypic Characteristics
Application:
13/542,000 →
Publication:
US 2012/0329086
Methods of Simulating Chemotherapy for a Patient
Application:
13/855,992 →
Publication:
US 2014/0072999
Methods for assessing efficacy of chemotherapeutic agents
Application:
60/417,439 →
Chemo-resistant cell assays
Application:
60/712,814 →
Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
Application:
60/712,815 →
Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
Application:
60/735,813 →
Materials and Methods for Prognosing Lung Cancer
Application:
60/865,960 →
Method for predicting a patient's response to an anti-angiogenesis agent
Application:
60/907,181 →
Methods for Selecting Chemotherapy Agents for Cancer Patients
Application:
60/980,098 →
Comparison of Angiogenesis-Related Factor Expression in Primary Tumor Cultures Under Normal and Hypoxic Growth Conditions
Application:
61/029,164 →
Methods of Predicting a Patient's Response to Egfr Tyrosine Kinase Inhibitors
Application:
61/053,094 →
Methods of Simulating Chemotherapy for a Patient
Application:
61/110,730 →
Methods for Predicting a Patient's Response to Egfr Inhibitors
Application:
61/142,809 →
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
Application:
61/182,445 →
Methods and Markers for Predicting Responses to Chemotherapy
Application:
61/187,108 →
Methods for Predicting a Cancer Patient's Response to Antifolate Chemotherapy
Application:
61/219,129 →
Multi Drug Resistance Markers for Breast Cancer Cells
Application:
61/265,588 →
Biological Pathways Associated with Chemotherapy Treatment in Breast Cancer
Application:
61/265,589 →
Methods for Predicting a Cancer Patient's Response to Sunitinib
Application:
61/306,784 →
Prognostic and Predictive Gene Signature for Non-Small Cell Lung Cancer and Adjuvant Chemotherapy
Application:
61/356,516 →
Multi Drug Response Markers for Breast Cancer Cells
Application:
61/364,446 →
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
Application:
61/417,678 →
Methods and Systems for Evaluating the Sensitivity or Resistance of Tumor Specimens to Chemotherapeutic Agents
Application:
61/469,364 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 1996
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 008163/0977 →
Assignment of Assignor's Interest
Jun 26, 1998
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 009280/0504 →
Assignment of Assignor's Interest
Aug 25, 1998
From: NAUS, GREGORY J.; KORNBLITH, PAUL L.; BURHOLT, DENNIS R.; MEYER, MICHAEL P.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 009412/0774 →
Assignment of Assignor's Interest
Feb 11, 1999
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 009752/0775 →
Security Interest
Jul 29, 1999
From: PRECISION THERAPEUTICS, INC.
To: NATIONAL CITY BANK OF PENNSYLVANIA
Reel/Frame 010121/0542 →
Assignment of Assignor's Interest
Jul 24, 2000
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 011003/0170 →
Assignment of Assignor's Interest
Oct 18, 2000
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 011218/0935 →
Certificate of Merger
Jul 2, 2001
From: PRECISION THERAPEUTICS, INC.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 011945/0189 →
Merger
Jan 8, 2002
From: PRECISION THERAPEUTICS, INC.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 012437/0785 →
Assignment of Assignor's Interest
Nov 27, 2002
From: KORNBLITH, PAUL L.; GIMIGLIANO, SHERI
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 013535/0877 →
Assignment of Assignor's Interest
Apr 15, 2003
From: KORNBLITH, PAUL L.; MCDONALD, SEAN
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 013952/0952 →
Assignment of Assignor's Interest
Aug 15, 2007
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 019690/0964 →
Release of Security Interest
Aug 22, 2007
From: NATIONAL CITY BANK OF PENNSYLVANIA
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 019725/0987 →
Assignment of Assignor's Interest
Dec 26, 2007
From: GABRIN, MICHAEL; BROWER, STACEY; MCDONALD, SEAN; GALLION, HOLY
To: PRECISION THERAPEUTICS INC.
Reel/Frame 020289/0262 →
Assignment of Assignor's Interest
Jul 8, 2009
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 022925/0955 →
Assignment of Assignor's Interest
Jul 28, 2009
From: MCDONALD, SEAN
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 023016/0394 →
Assignment of Assignor's Interest
Sep 21, 2010
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 025017/0421 →
Assignment of Assignor's Interest
Jan 30, 2012
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 027617/0693 →
Assignment of Assignor's Interest
Mar 5, 2012
From: KORNBLITH, PAUL L.; GIMIGLIANO, SHERI
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 027804/0765 →
Security Agreement
Mar 23, 2012
From: PRECISION THERAPEUTICS, INC.
To: COWEN HEALTHCARE ROYALTY PARTNERS II, L.P.
Reel/Frame 027922/0459 →
Assignment of Assignor's Interest
Dec 5, 2016
From: HELOMICS CORPORATION
To: CYTOMICS, INC.
Reel/Frame 040529/0022 →